148 related articles for article (PubMed ID: 9781942)
1. Hepatitis C virus infection associated with human hepatocellular carcinoma: lack of correlation with p53 abnormalities in Caucasian patients.
Pontisso P; Belluco C; Bertorelle R; De Moliner L; Chieco-Bianchi L; Nitti D; Lise M; Alberti A
Cancer; 1998 Oct; 83(8):1489-94. PubMed ID: 9781942
[TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
Shieh YS; Nguyen C; Vocal MV; Chu HW
Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
[TBL] [Abstract][Full Text] [Related]
3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
4. P53 mutations in hepatocellular carcinoma patients in Egypt.
El-Kafrawy SA; Abdel-Hamid M; El-Daly M; Nada O; Ismail A; Ezzat S; Abdel-Latif S; Abdel-Hamid A; Shields PG; Loffredo C
Int J Hyg Environ Health; 2005; 208(4):263-70. PubMed ID: 16078640
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
6. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
7. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
8. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G
World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
10. p53 mutation in HCV-genotype-4 associated hepatocellular carcinoma in Egyptian patients.
Zekri AR; Bahnassy AA; Madbouly MS; Asaad NY; El-Shehaby AM; Alam El Din HM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):17-29. PubMed ID: 17237848
[TBL] [Abstract][Full Text] [Related]
11. Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients.
Leveri M; Gritti C; Rossi L; Zavaglia C; Civardi E; Mondelli MU; De Silvestri A; Silini EM
Cancer Lett; 2004 May; 208(1):75-9. PubMed ID: 15105048
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutation spectrum in hepatocellular carcinoma.
Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
[TBL] [Abstract][Full Text] [Related]
13. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.
Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC
J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620
[TBL] [Abstract][Full Text] [Related]
14. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of hepatocarcinogenesis.
Sheu JC
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
[TBL] [Abstract][Full Text] [Related]
16. Ligation-Mediated Polymerase Chain Reaction Detection of 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine and 5-Hydroxycytosine at the Codon 176 of the p53 Gene of Hepatitis C-Associated Hepatocellular Carcinoma Patients.
Galli A; Munnia A; Cellai F; Tarocchi M; Ceni E; van Schooten FJ; Godschalk R; Giese RW; Peluso M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942546
[TBL] [Abstract][Full Text] [Related]
17. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
Teramoto T; Satonaka K; Kitazawa S; Fujimori T; Hayashi K; Maeda S
Cancer Res; 1994 Jan; 54(1):231-5. PubMed ID: 8261444
[TBL] [Abstract][Full Text] [Related]
18. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
19. [Study on p53 gene mutation in hepatocellular carcinoma patients in China].
Kang G; Fang Z; Volkmann M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):163-5. PubMed ID: 11436649
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma.
Anzola M; Cuevas N; López-Martínez M; Saiz A; Burgos JJ; de Pancorbo MM
Cancer Lett; 2003 Apr; 193(2):199-205. PubMed ID: 12706878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
